Chemical profiling of Thevetia peruviana leaves cytotoxic active extracts enhanced by microemulsion formulation

Author:

El-Sawi Salma A.,Maamoun Amal A.ORCID,Salama Alaa H.,Farghaly Ayman A.

Abstract

Abstract Background Natural products played an essential role as a complementary cytotoxic agent avoiding complications of other therapies. In phytoformulation research, herbal drugs of nano-size have attracted more attention for more bioavailability and less active dose. We aim in this work to introduce new non-mutagenic cytotoxic agent from Thevetia peruviana leaves extracts and potentiate the activity by loading upon microemulsion formulations as an advanced mode of drug delivery system. Results Thevetia peruviana toxicity test revealed its safety (LD50 = 3.083 g/kg). In vivo genotoxicity tests measuring chromosomal aberrations were done to prove non-mutagenicity of the plant for both somatic and germ cells. The plant showed antioxidant activity with 121.215, 128.925, and 120.098 mg/g extract, calculated as Trolox equivalent (TE/g) for DPPH, ABTS, and FRAP assays, respectively. Successive extracts of the plant were incorporated in microemulsion formulations (MEF) and characterized for their electrical conductivity, poly-dispersity index, and in vitro drug release action. Cytotoxic activity of successive extracts was investigated against breast MCF7 and liver HEPG2 carcinoma cell lines before and after loading upon MEs. Enhancement in activity was detected for both pet. ether and ethanol MEFs, as IC50 of pet. ether extract decreased from 25 to 6.5 μg/ml against MCF7 cell line, while ethanol formulation recorded IC50 = 3.58 μg/ml against HEPG2 cell line after showing no activity of the extract at the tested concentrations. Regarding metabolites of polar fraction, total ethanol extract was estimated for total phenolic and flavonoid contents to record 47.7941 mg GAE/g calculated as gallic acid equivalent and 32.7667 mg CE/g measured as catechin equivalent, respectively. HPLC analysis for polar fraction recorded twelve compounds identified according to the available authentics with rutin the major flavonoid (7.33 mg/g) and rosmarinic acid (13.48 mg/g) the most abundant phenolic acid. Phytoconstituents of non-polar fraction were investigated after saponification of pet. ether extract using GC/MS analysis revealed the identification of 88.02% of the total unsaponifiable matter and 89.17 % of the total saponifiable matter. Conclusion Thevetia peruviana is a safe cytotoxic agent. Microemulsion formulations of active extracts potentiate the cytotoxic actions against HEPG2 and MCF7 cell lines with better bioavailability and less medicinal doses.

Funder

National Research Centre

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference53 articles.

1. Aboutab E, Hashem F, Sleem A, Maamoun A (2010) Phytochemical and bioactivity investigations of Macfadyena unguis-cati L.(Bignoniaceae). Plant Products Research Journal 14(1):19–27

2. Adams R (2009) Identification of essential oil compounds by gas chromatography/mass spectroscopy, 4th edn. Allured Publishing Corporation, USA

3. Akihisa T, Kokke W. C. M. C., Tamura, T. In Physiology and Biochemistry of Sterols;. In: Patterson GW, Nes, W. D., , editor. American Oil Chemists’ Society: Champaign, IL; 1991.

4. Aly FA,  Farghaly AA,  Salman AS,  Hassan EM,  Hassan EE,Omara EA, Salama AB (2019) Protective Effect of Rosmarinus officinalis Essential Oil Against Genotoxic and Histopathological Alterations Induced by Paracetamol. Int J Pharmacol 15(6):686-95.

5. Appa Rao M, Venkata E, Visweswaram D (1978) Effect of certain structural changes in cardiac glycosides of Thevetia peruviana on their toxicity. J Mol Cell Cardiol 10(Suppl. 1):86

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3